(S)-5,6-Difluoro-2,3-dihydro-1H-inden-1-amine is primarily used in pharmaceutical research and development, particularly in the synthesis of compounds targeting central nervous system disorders. Its structure makes it a valuable intermediate in creating molecules that interact with specific receptors in the brain, potentially leading to treatments for conditions like depression, anxiety, or neurodegenerative diseases. Additionally, its chiral nature allows for the development of enantiomerically pure drugs, enhancing efficacy and reducing side effects. Researchers also explore its utility in designing novel therapeutic agents due to its unique fluorine substitution, which can improve metabolic stability and bioavailability.